Clinical Trial Update: 13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating completion of the study evaluating the 13-valent pneumococcal conjugate vaccine in patients with chronic kidney disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: AZ Sint-Jan AV | Conditions: Chronic Kidney Failure | Phase 4 | Status: COMPLETED